
VRDN EPS Estimates
Viridian Therapeutics, Inc.
$30.12
+$0.06(+0.20%)
59
Overall
60
Value
83
Tech
34
Quality
Market Cap
$3.42B
Volume
1.49M
52W Range
$13.18 - $34.29
Target Price
$42.06
VRDN EPS estimates: the consensus estimate for Viridian Therapeutics, Inc.'s current fiscal year is -$3.64 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VRDN EPS Estimates
- EPS estimate, current quarter
- $-0.81
- EPS estimate, next quarter
- $-0.61
- EPS estimate, current year
- $-3.64
- EPS estimate, next year
- $-2.13
- EPS growth, 3-year
- +6.41%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.32 |
| 2024 | $-3.07 |
| 2023 | $-5.31 |
| 2022 | $-4.05 |
| 2021 | $-6.66 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $30.12 | +0.2% | 1.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW